Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 12 studies | 27% ± 11% | |
| goblet cell | 7 studies | 22% ± 6% | |
| epithelial cell | 6 studies | 38% ± 14% | |
| type I pneumocyte | 6 studies | 20% ± 2% | |
| endothelial cell | 5 studies | 22% ± 4% | |
| oligodendrocyte | 4 studies | 24% ± 6% | |
| GABAergic neuron | 3 studies | 39% ± 5% | |
| glutamatergic neuron | 3 studies | 44% ± 7% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 6% | |
| enterocyte | 3 studies | 19% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1712.29 | 1445 / 1445 | 99% | 10.99 | 182 / 183 |
| prostate | 100% | 2086.29 | 245 / 245 | 99% | 12.19 | 498 / 502 |
| lung | 100% | 2123.28 | 577 / 578 | 99% | 7.63 | 1141 / 1155 |
| breast | 100% | 2138.27 | 459 / 459 | 98% | 10.09 | 1093 / 1118 |
| ovary | 100% | 1511.25 | 180 / 180 | 98% | 5.01 | 420 / 430 |
| stomach | 100% | 2286.47 | 359 / 359 | 97% | 10.90 | 278 / 286 |
| intestine | 100% | 3672.68 | 966 / 966 | 97% | 11.31 | 512 / 527 |
| thymus | 100% | 2477.20 | 653 / 653 | 96% | 7.04 | 580 / 605 |
| bladder | 100% | 1679.43 | 21 / 21 | 93% | 6.67 | 470 / 504 |
| pancreas | 100% | 1181.32 | 328 / 328 | 93% | 5.73 | 165 / 178 |
| kidney | 100% | 1326.08 | 89 / 89 | 90% | 4.78 | 815 / 901 |
| uterus | 100% | 1794.17 | 170 / 170 | 90% | 6.06 | 415 / 459 |
| brain | 99% | 1065.76 | 2624 / 2642 | 89% | 2.94 | 624 / 705 |
| liver | 100% | 1901.58 | 226 / 226 | 82% | 3.87 | 333 / 406 |
| skin | 100% | 1824.35 | 1808 / 1809 | 62% | 2.15 | 291 / 472 |
| adrenal gland | 100% | 1306.36 | 258 / 258 | 29% | 0.79 | 66 / 230 |
| adipose | 100% | 1816.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1879.91 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1373.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.49 | 1 / 1 |
| muscle | 98% | 653.09 | 789 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 755.57 | 833 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 84% | 4.74 | 38 / 45 |
| peripheral blood | 43% | 582.03 | 400 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 1.14 | 12 / 29 |
| eye | 0% | 0 | 0 / 0 | 10% | 0.28 | 8 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0097624 | Biological process | UDP-galactose transmembrane import into Golgi lumen |
| GO_0006047 | Biological process | UDP-N-acetylglucosamine metabolic process |
| GO_1990569 | Biological process | UDP-N-acetylglucosamine transmembrane transport |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005462 | Molecular function | UDP-N-acetylglucosamine transmembrane transporter activity |
| GO_0015297 | Molecular function | antiporter activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005459 | Molecular function | UDP-galactose transmembrane transporter activity |
| Gene name | SLC35A3 |
| Protein name | Solute carrier family 35 member A3 UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3) |
| Synonyms | |
| Description | FUNCTION: Transports diphosphate-N-acetylglucosamine (UDP-GlcNAc) from the cytosol into the lumen of the Golgi apparatus, functioning as an antiporter that exchanges UDP-N-acetyl-alpha-D-glucosamine for UMP . May supply UDP-GlcNAc as substrate for Golgi-resident glycosyltransferases that generate highly branched, multiantennary complex N-glycans and keratan sulfate . However, the exact role of SLC35A3 still needs to be elucidated, it could be a member of a catalytically more efficient multiprotein complex rather than function independently as a single transporter . . |
| Accessions | ENST00000639148.1 ENST00000639994.1 ENST00000532693.5 ENST00000638338.1 ENST00000465289.6 [Q9Y2D2-1] E9PPQ9 ENST00000640732.1 A0A1W2PRN3 ENST00000640178.1 A0A1W2PNY6 A0A1W2PRT7 ENST00000427993.7 [Q9Y2D2-1] ENST00000640238.1 A0A1W2PNF0 ENST00000638876.1 A0A1W2PSD1 ENST00000639088.1 ENST00000640715.1 A0A1W2PQ60 ENST00000370153.6 [Q9Y2D2-2] A0A1W2PPH4 ENST00000638988.1 ENST00000638371.1 A0A1W2PP85 A0A1W2PPW2 ENST00000533028.8 [Q9Y2D2-1] ENST00000638336.1 [Q9Y2D2-3] A0A1W2PQL8 A0A1C7CYW3 ENST00000639221.1 ENST00000640726.1 ENST00000640360.1 ENST00000370155.9 A0A1W2PQH2 A0A1W2PR66 ENST00000640600.1 ENST00000639807.1 Q9Y2D2 |
